Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

Ancor Acquires WellSpring Pharmaceuticals

November 7, 2011 11:55 am | News | Comments

Ancor Capital Partners acquired WellSpring Pharmaceuticals, a manufacturer and marketer of specialty prescription and over-the-counter products in North America, as well as contract manufacturing services.


Researchers Devise Key Taxol Production Step

November 7, 2011 11:51 am | News | Comments

Finding an efficient way to produce Taxol, a highly successful drug used to treat ovarian, breast, lung, liver, and other cancer types, in the laboratory remains one of the most sought-after goals in organic chemistry.

Final Results Released for Hepatitis C Drug

November 7, 2011 11:48 am | News | Comments

Tibotec Pharmaceuticals announced the final analysis of Pillar, a Phase 2b study of the investigational hepatitis C virus NS3/4A protease inhibitor TMC435 in patients with chronic genotype 1 HCV.


Genes Discovered In Colorectal Cancer

November 7, 2011 11:35 am | News | Comments

A jumping gene with the fairy tale name 'Sleeping Beauty' has helped to unlock vital clues for researchers investigating the genetics of colorectal cancer.

Compliance Software

November 7, 2011 7:17 am | Product Releases | Comments

PerkinElmer, Inc. introduced the NexION Enhanced Security Software, to streamline regulatory compliance by pharmaceutical companies. The ES Software platform was developed for users of PerkinElmer's NexION 300 ICP-MS system.


Dishwasher Thermometer

November 7, 2011 7:14 am | Product Releases | Comments

Control Company’s Traceable dishwasher metal thermometer reports the maximum and minimum temperatures insures proper cleaning by providing proof of meeting the temperature regulation of 180°F during dishwashing.


Horizon Discovery Partnering with Promega

November 7, 2011 6:53 am | News | Comments

Horizon Discovery Ltd. announced a partnership with Promega Corporation centering on the delivery of endogenous gene reporting capabilities, in the form of Promega’s luciferase and HaloTag reporters, using Horizon’s genome editing technology.


Ardea Biosciences Reports $22M Loss

November 7, 2011 6:28 am | News | Comments

Ardea Biosciences Inc. reported a larger third-quarter loss as it continued to develop its gout drug candidates and its revenue decreased. Ardea said its net loss amounted to $22.5 million, or 84 cents per share, for the three months ended Sept. 30.


NicVAX Falls Flat in Late-Stage Trial

November 7, 2011 6:24 am | News | Comments

Nabi Biopharmaceuticals announced that NicVAX did not meet its primary endpoint in the second of two confirmatory Phase 3 clinical trials. An assessment of the trial data showed that no statistical difference between the NicVAX and placebo groups.


FDA Clears Xarelto for Atrial Fibrillation

November 7, 2011 6:14 am | News | Comments

More than 2 million new U.S. patients will be eligible to receive a next-generation blood thinner drug called Xarelto, after the Food and Drug Administration approved the medication to treat a common heart problem that can lead to stroke.


INX-189 Performs Well in New Study

November 7, 2011 6:10 am | News | Comments

Pharmaceutical company Inhibitex Inc. said early data from a mid-stage study showed that a 200-milligram dose of its potential hepatitis C treatment did well in reducing the virus in patients.


Amag CEO Resigns; Major Job Cuts Ahead

November 7, 2011 6:07 am | News | Comments

Drug developer Amag Pharmaceuticals Inc. said its CEO had resigned and the company will begin a restructuring that includes cutting about 25% of its jobs and as much as $25 million in operating expenses.


Warner Chilcott Profit Drops 42%

November 7, 2011 6:04 am | News | Comments

Warner Chilcott PLC said its profit fell 42% in the third quarter as revenue from one of its biggest drugs, an osteoporosis treatment, fell sharply, and it had to pay for job cuts in Western Europe.


Tamper-Evident Outer Packaging Seals

November 4, 2011 12:16 pm | Product Releases | Comments

Avantor Performance Materials will offer tamper-evident outer packaging seals for all regulated pharmaceutical raw material and excipient containers by the end of 2011.

Cleanroom for Fluid Handling Components

November 4, 2011 12:12 pm | Product Releases | Comments

Diba’s Class 10,000 cleanroom is a hard wall 20’ x 30’ ISO 7 single pass cleanroom with dual 36” pass-through ports and a gowning room.


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.